- Home
- FSM vs VCEL Comparison
FSM vs VCEL Comparison
Compare FSM & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FSM
- VCEL
- Stock Information
- Founded
- FSM 1990
- VCEL 1989
- Country
- FSM Canada
- VCEL United States
- Employees
- FSM N/A
- VCEL N/A
- Industry
- FSM Precious Metals
- VCEL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FSM Basic Materials
- VCEL Health Care
- Exchange
- FSM Nasdaq
- VCEL Nasdaq
- Market Cap
- FSM 2.3B
- VCEL 2.1B
- IPO Year
- FSM N/A
- VCEL 1997
- Fundamental
- Price
- FSM $6.59
- VCEL $36.24
- Analyst Decision
- FSM Hold
- VCEL Strong Buy
- Analyst Count
- FSM 1
- VCEL 7
- Target Price
- FSM $8.00
- VCEL $61.29
- AVG Volume (30 Days)
- FSM 11.4M
- VCEL 661.7K
- Earning Date
- FSM 08-06-2025
- VCEL 07-31-2025
- Dividend Yield
- FSM N/A
- VCEL N/A
- EPS Growth
- FSM 7355.92
- VCEL 2045.40
- EPS
- FSM 0.50
- VCEL 0.13
- Revenue
- FSM $1,187,211,000.00
- VCEL $249,119,000.00
- Revenue This Year
- FSM N/A
- VCEL $23.03
- Revenue Next Year
- FSM N/A
- VCEL $24.51
- P/E Ratio
- FSM $12.81
- VCEL $271.36
- Revenue Growth
- FSM 46.81
- VCEL 16.13
- 52 Week Low
- FSM $4.10
- VCEL $33.09
- 52 Week High
- FSM $7.55
- VCEL $63.00
- Technical
- Relative Strength Index (RSI)
- FSM 49.13
- VCEL 42.21
- Support Level
- FSM $6.17
- VCEL $35.23
- Resistance Level
- FSM $7.10
- VCEL $36.81
- Average True Range (ATR)
- FSM 0.29
- VCEL 1.92
- MACD
- FSM -0.02
- VCEL -0.15
- Stochastic Oscillator
- FSM 44.62
- VCEL 36.25
About FSM Fortuna Silver Mines Inc (Canada)
Fortuna Mining Corp is a Canadian-based precious metals mining company with mines in the Latin America and West Africa regions producing gold and silver. It operate mines in Argentina, Burkina Faso, Cote d'Ivoire, Mexico, and Peru. The company's segment consists of Mansfield, Sanu, Sango, Cuzcatlan, Bateas, Corporate. The company generates the majority of its revenue from Sango segment which operates the Seguela gold mine. Geographically, the company generates the majority of its revenue from Cote d'Ivoire location.
About VCEL Vericel Corporation
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.